KYNTRA BIO, INC. (KYNB) Gross profit 2019–2025
KYNTRA BIO, INC. (KYNB) annual gross profit history from SEC filings — each fiscal year as reported.
$5.9MFY2025 · since FY2019: $255.4M → $5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.9M | -58.2% |
| FY2024 | $14.1M | -67.2% |
| FY2023 | $42.8M | -64.4% |
| FY2022 | $120.5M | -45.8% |
| FY2021 | $222.4M | +32.8% |
| FY2020 | $167.4M | -34.4% |
| FY2019 | $255.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KYNB financial trends
KYNB RevenueKYNB Net incomeKYNB Net marginKYNB Gross marginKYNB Operating incomeKYNB Operating marginKYNB Operating cash flowKYNB Free cash flowKYNB Capital expendituresKYNB Return on equityKYNB Stock buybacksKYNB Dividends paidKYNB Total assetsKYNB Total liabilitiesKYNB Shareholders’ equityKYNB overview →